1 |
Alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
2 |
Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994 |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
046 1件: 46 💬 |
3 |
Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
046 1件: 46 💬 |
4 |
Alemtuzumab (campath ) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
060 1件: 60 💬 |
5 |
Alemtuzumab (campath) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
015 1件: 15 💬 |
6 |
Alemtuzumab (gz402673) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
7 |
Alemtuzumab 0.2 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
065 2件: 65, 164 💬 |
8 |
Alemtuzumab 0.3 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
065 2件: 65, 164 💬 |
9 |
Alemtuzumab 12 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
10 |
Alemtuzumab 24 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
11 |
Alemtuzumab and rituximab |
Alemtuzumab |
2件: D02802 D02802, D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
060 1件: 60 💬 |
12 |
Alemtuzumab gz402673 |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
13 |
Alemtuzumab immunotherapy |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
14 |
Alemtuzumab injection |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
15 |
Alemtuzumab injection [lemtrada] |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
16 |
Alemtuzumab, rituximab |
Alemtuzumab |
2件: D02802 D02802, D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
063 1件: 63 💬 |
17 |
Alentuzumab (campath) |
- |
- |
- |
- |
065 1件: 65 💬 |
18 |
Campath |
- |
- |
- |
- |
019 12件: 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬 |
19 |
Campath -1h |
- |
- |
- |
- |
065 1件: 65 💬 |
20 |
Campath 1h |
- |
- |
- |
- |
060 4件: 60, 65, 164, 285 💬 |
21 |
Campath, busulfan, clofarabine |
Busulfan |
2件: D00248 D00248, D03546 D03546 💬 |
POLA1 3件: POLA1, POLA2, RRM1 💬 |
DNA replication 6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
326 1件: 326 💬 |
22 |
Campath, chemo and/or tbi allo sct |
- |
- |
- |
- |
060 3件: 60, 62, 283 💬 |
23 |
Campath, fludarabine, cyclophosphamide |
Cyclophosphamide |
4件: D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 2件: 65, 284 💬 |
24 |
Campath-1h |
- |
- |
- |
- |
019 6件: 19, 20, 60, 234, 285, 326 💬 |
25 |
Campath-1h (alemtuzumab) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
060 1件: 60 💬 |
26 |
Cyclophosphamide,campath ih and tbi |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
060 1件: 60 💬 |
27 |
Filgrastim, alemtuzumab |
Alemtuzumab |
2件: D02802 D02802, D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
065 1件: 65 💬 |
28 |
Transplant conditioning with mobilization and alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
065 1件: 65 💬 |
29 |
Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan |
Alemtuzumab |
5件: D00369 D00369, D00583 D00583, D01907 D01907, D02802 D02802, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 2件: 65, 164 💬 |